Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 436314, 5 pages
http://dx.doi.org/10.1155/2015/436314
Review Article

Stem Cell-Based Therapies in Chagasic Cardiomyopathy

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rua Carlos Chagas Filho 373, 21949-900 Rio de Janeiro, RJ, Brazil

Received 24 March 2015; Accepted 27 May 2015

Academic Editor: Junjie Xing

Copyright © 2015 Antonio Carlos Campos de Carvalho and Adriana Bastos Carvalho. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Chagas, “Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem,” Memórias do Instituto Oswaldo Cruz, vol. 1, no. 2, pp. 159–218, 1909. View at Publisher · View at Google Scholar
  2. M. C. P. Nunes, W. Dones, C. A. Morillo, J. J. Encina, and A. L. Ribeiro, “Chagas disease: an overview of clinical and epidemiological aspects,” Journal of the American College of Cardiology, vol. 62, no. 9, pp. 767–776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. R. Coura and P. A. Vĩas, “Chagas disease: a new worldwide challenge,” Nature, vol. 465, no. 7301, pp. S6–S7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Rassi Jr. and J. A. Marin-Neto, “Chagas disease,” The Lancet, vol. 375, no. 9723, pp. 1388–1402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. B. Tanowitz, F. S. Machado, L. A. Jelicks et al., “Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease),” Progress in Cardiovascular Diseases, vol. 51, no. 6, pp. 524–539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Marin-Neto, E. Cunha-Neto, B. C. Maciel, and M. V. Simões, “Pathogenesis of chronic Chagas heart disease,” Circulation, vol. 115, no. 9, pp. 1109–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. B. P. Soares, R. S. Lima, L. L. Rocha et al., “Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice,” American Journal of Pathology, vol. 164, no. 2, pp. 441–447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. S. Goldenberg, L. A. Jelicks, F. S. A. Fortes et al., “Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model,” Journal of Infectious Diseases, vol. 197, no. 4, pp. 544–547, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. B. P. Soares, R. S. Lima, B. S. F. Souza et al., “Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells,” Cell Cycle, vol. 10, no. 9, pp. 1448–1455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. C. Guarita-Souza, K. A. T. Carvalho, V. Woitowicz et al., “Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease,” Circulation, vol. 114, no. 1, pp. I120–I124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Tolar, K. le Blanc, A. Keating, and B. R. Blazar, “Concise review: hitting the right spot with mesenchymal stromal cells,” Stem Cells, vol. 28, no. 8, pp. 1446–1455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Makino, K. Fukuda, S. Miyoshi et al., “Cardiomyocytes can be generated from marrow stromal cells in vitro,” Journal of Clinical Investigation, vol. 103, no. 5, pp. 697–705, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. Jasmin, L. A. Jelicks, W. Koba et al., “Mesenchymal bone marrow cell therapy in a mouse model of Chagas disease. Where do the cells go?” PLoS Neglected Tropical Diseases, vol. 6, no. 12, Article ID e1971, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Jasmin, L. A. Jelicks, H. B. Tanowitz et al., “Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease,” Microbes and Infection, vol. 16, no. 11, pp. 923–935, 2014. View at Publisher · View at Google Scholar
  15. F. Vilas-Boas, G. S. Feitosa, M. B. P. Soares et al., “Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to chagas disease,” Arquivos Brasileiros de Cardiologia, vol. 87, no. 2, pp. 159–166, 2006. View at Google Scholar · View at Scopus
  16. S. G. Macambira, J. F. Vasconcelos, C. R. S. Costa et al., “Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function,” The FASEB Journal, vol. 23, no. 11, pp. 3843–3850, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. M. B. da Fonseca, S. S. Xavier, P. H. R. de Castro et al., “Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection,” International Journal of Cardiology, vol. 129, no. 3, pp. 310–314, 2011. View at Publisher · View at Google Scholar
  18. R. R. dos Santos, S. Rassi, G. Feitosa et al., “Cell therapy in chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial,” Circulation, vol. 125, no. 20, pp. 2454–2461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. M. D. M. Guedes, F. R. S. Gutierrez, F. L. Maia et al., “IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis,” PLoS Neglected Tropical Diseases, vol. 4, no. 2, article e604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Kierszenbaum, “Where do we stand on the autoimmunity hypothesis of Chagas disease?” Trends in Parasitology, vol. 21, no. 11, pp. 513–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. W. O. Dutra, M. O. C. Rocha, and M. M. Teixeira, “The clinical immunology of human Chagas disease,” Trends in Parasitology, vol. 21, no. 12, pp. 581–587, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Chandra, J. Shirani, V. Shtutin et al., “Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study,” International Journal for Parasitology, vol. 32, no. 2, pp. 207–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. P. de Souza, B. Tang, H. B. Tanowitz, T. C. Araújo-Jorge, and E. L. A. Jelicks, “Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation,” Parasitology Research, vol. 97, no. 2, pp. 87–90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. D. W. Losordo, T. D. Henry, C. Davidson et al., “Intramyocardial, autologous CD34+ cell therapy for refractory angina,” Circulation Research, vol. 109, no. 4, pp. 428–436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Schächinger, S. Erbs, A. Elsässer et al., “Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1210–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., “Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial,” The Journal of the American Medical Association, vol. 308, no. 22, pp. 2369–2379, 2012. View at Publisher · View at Google Scholar
  27. E. C. Perin, H. F. R. Dohmann, R. Borojevic et al., “Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy,” Circulation, vol. 110, no. 11, pp. II213–II218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. P. M. M. Guedes, V. M. Veloso, L. C. C. Afonso et al., “Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-γ, TNF-α, and low IL-10 production during the acute infection phase,” Veterinary Immunology and Immunopathology, vol. 130, no. 1-2, pp. 43–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Daliry, I. S. Caldas, L. D. F. Diniz et al., “Anti-adrenergic and muscarinic receptor autoantibodies in a canine model of Chagas disease and their modulation by benznidazole,” International Journal of Cardiology, vol. 170, no. 3, pp. e66–e67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. F. S. Loffredo, M. L. Steinhauser, J. Gannon, and R. T. Lee, “Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair,” Cell Stem Cell, vol. 8, no. 4, pp. 389–398, 2011. View at Publisher · View at Google Scholar · View at Scopus